[1]李强 孙翠梅 刘建强等.血浆胱氨酸蛋白酶抑制剂C水平与脑小血管病关系的研究[J].卒中与神经疾病杂志,2016,23(01):12-14.[doi:10.3969/j.issn.1007-0478.2016.01.004]
 Li Qiang,Sun Cuimei,Liu Jianqiang,et al.The clinical reserch on level of plasma cystatin C in small vessel disease[J].Stroke and Nervous Diseases,2016,23(01):12-14.[doi:10.3969/j.issn.1007-0478.2016.01.004]
点击复制

血浆胱氨酸蛋白酶抑制剂C水平与脑小血管病关系的研究()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第23卷
期数:
2016年01期
页码:
12-14
栏目:
论著
出版日期:
2016-03-01

文章信息/Info

Title:
The clinical reserch on level of plasma cystatin C in small vessel disease
作者:
李强 孙翠梅 刘建强等
作者单位: 255036 山东省淄博市中心医院神经内科[李强 孙翠梅(通信作者)刘建强 薛浩]
Author(s):
Li Qiang Sun Cuimei Liu Jianqiang et al
Central Hospital of Zibo City, Zibo 255036
关键词:
脑小血管病 小动脉硬化 胱氨酸蛋白酶抑制剂C
Keywords:
Small vessel disease Arteriolar sclerosis Cystatin C
分类号:
R743
DOI:
10.3969/j.issn.1007-0478.2016.01.004
文献标志码:
A
摘要:
目的 探讨血浆胱氨酸蛋白酶抑制剂C(胱抑素C)水平与脑小血管病(cerebral small vessel disease,CSVD)的关系。方法 选取经MRI确诊的脑小血管病患者(观察组)61例及同期MRI检查正常者(对照组)53例,采用颗粒增强免疫比浊法测定观察组和对照组胱抑素C水平,并且对胱抑素C水平与脑小血管病的相关性进行分析。结果 脑小血管病患者胱抑素C水平显著高于对照组(P<0.01); 进行多因素logistic回归分析显示,Cys C水平升高与CSVD的发生显著相关(OR 5.978,95% CI 4.847-11.471,P<0.01)。结论 Cys C水平升高是CSVD发生的独立危险因素,可以预测CSVD发生的危险性。
Abstract:
ObjectiveTo observe the correlation between plasma Cystatin C(Cys C)and the cerebral small vessel disease(CSVD).Methods 61 patients with cerebral small vessel disease diagnosed by MRI and 53 healthy subjects were recruited in this study. Level of Cys C was tested by particle enhanced immune nephelo-metric assay. All patients were divided into four groups based on Cys C level. The relationship between plasma Cys C and small vessel disease was analyzed by logistic regression.Results Compared with healthy subjects, level of plasma Cys C was significantly higher in the patients group, and logistic regression revealed that the risk ratios for the SVD with gradually higher level of Cvs C were 1; 1.27(1.08~1.52); 1.73(1.22~2.61); 2.13(1.49~3.05).Conclusion It is suggested that high level of plasma Cys C may be a risk factor of SVD.

参考文献/References:

[1] O'BRIEN JT, ERKINJUNTTI T, REISBERG B, et al. Vascular cognitive impairment[J]. Lancet Neurolog, 2003, 2(2): 89-98.
[2] 张微微.脑小血管病[J].中华老年心脑血管病杂志,2009,11(12):939-940.
[3] O'ROURKE MF, SAFAR ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy[J]. Hypertension, 2005, 46(1): 200-204.
[4] GRUBB AO. Cystatin C-properties and use as diagnostic marker[J]. Advances in Clinical Chemistry, 2000, 35: 63-99.
[5] MUSSAP M, PLEBANI M. Biochemistry and clinical role of human cystatin C[J]. Critical Reviews in Clinical Laboratory Sciences, 2004, 41(5/6): 467-550.
[6] NI L, Lü J, HOU LB, et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese[J]. Stroke; a Journal of Cerebral Circulation, 2007, 38(12): 3287-3288.
[7] FOGO A, BREYER JA, SMITH MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease(AASK)Trial. AASK Pilot Study Investigators[J]. Kidney International, 1997, 51(1):244-252.
[8] KHATRI M, WRIGHT CB, NICKOLAS TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study(NOMAS)[J]. Stroke, a Journal of Cerebral Circulation, 2007, 38(12): 3121-3126.
[9] NAGANUMA T, UCHIDA J, TSUCHIDA K, et al. Silent cerebral infarction predicts vascular events in hemodialysis patients[J]. Kidney International, 2005, 67(6): 2434-2439.
[10] BENGTSSON E, TO F, GRUBB A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice[J]. Atherosclerosis, 2005, 180(1): 45-53.
[11] SHLIPAK MG, SARNAK MJ, KATZ R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons[J]. New England Journal of Medicine, 2005, 352(20): 2049-2060.
[12] SELIGER SL, LONGSTRETH WT, KATZ R, et al. Cystatin C and subclinical brain infarction[J]. Journal of the American Society of Nephrology, 2005, 16(12): 3721-3727.

更新日期/Last Update: 1900-01-01